Online inquiry

IVTScrip™ mRNA-Human ADGRL3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8947MR)

This product GTTS-WK8947MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRL3 protein. This product can be used in FGFR1 High NME5-epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001322246.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23284
UniProt ID Q9HAR2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRL3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8947MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16137MR IVTScrip™ mRNA-Human ANKRD9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD9
GTTS-WK10358MR IVTScrip™ mRNA-Human ACTC1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACTC1
GTTS-WK21797MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASB16-AS1
GTTS-WK17837MR IVTScrip™ mRNA-Human alpha-SMA, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA alpha-SMA
GTTS-WK3318MR IVTScrip™ mRNA-Human SOST, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA SOST
GTTS-WK19418MR IVTScrip™ mRNA-Human ANKRD32, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD32
GTTS-WK10109MR IVTScrip™ mRNA-Human ADAMTSL3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADAMTSL3
GTTS-WK25604MR IVTScrip™ mRNA-Human ARHGDIA, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGDIA
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →